High BMI, Male Gender Predict Colon Polyps in Younger Patients (CME/CE)
(MedPage Today) -- Chronic kidney disease also a risk factor, study finds (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 7, 2018 Category: Urology & Nephrology Source Type: news

Medical News Today: What to know about bladder polyps
Bladder polyps occur when abnormal cells grow in the bladder. Polyps can have no symptoms, though some people have symptoms similar to a urinary tract infection. Polyps can be benign or cancerous. Read on to find out about the symptoms and causes of polyps in the bladder, as well as when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 5, 2018 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

AI Detects Polyps Better Than Colonoscopists AI Detects Polyps Better Than Colonoscopists
A machine-learning model helps expert reviewers identify more polyps than they would without the assistance of artificial intelligence (AI), new research shows.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 3, 2018 Category: Radiology Tags: Gastroenterology News Source Type: news

Blue-Dye Tablet During Bowel Prep Boosts Polyp Detection Rate Blue-Dye Tablet During Bowel Prep Boosts Polyp Detection Rate
Swallowing a tablet of delayed-release methylene blue during bowel preparation for colonoscopy increases detection of adenomas, particularly hard-to-detect ones that are flat or subtle, according to results of a randomized, placebo-controlled trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 1, 2018 Category: Surgery Tags: Gastroenterology News Source Type: news

PENTAX Medical Announces U.S. Deal To Distribute Third Eye(R) Panoramic(TM) Imaging System For Colon Cancer Screening
Provides 'Panoramic' View to Detect Potentially Cancerous Polyps Standard Colonoscopes May Not See MONTVALE, N.J., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical Company, a healthcare industry leader in diagnostic and therapeu... Devices, Gastroenterology, Oncology, Distribution PENTAX Medical, Avantis Medical Systems, Third Eye, colonoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Lumendi wins FDA nod for DiLumen IS endoscopic scissors
Lumendi said today it won FDA 510(k) clearance for its DiLumen IS endolumenal interventional scissors, now indicated for cutting, dissecting and cauterizing tissue within the digestive tract during endoscopic procedures. The Westport, Conn.-based company touted the sterile, single-use disposable, monopolar electrosurgical device as the fourth it’s developed, and said that it and its recently cleared DiLumen CT are intended to help improve access and therapy in the colon and reduce the need for surgical interventions. The recently cleared C2  is a second-gen Endolumenal interventional platform designed to en...
Source: Mass Device - May 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Lumendi Source Type: news

Bringing AI to Colorectal Cancer Screening
Freenome is looking to build a diagnostic test that can learn from its mistakes. The South San Francisco, CA- based company is using artificial intelligence to improve colorectal cancer screening. To do this, Freenome has initiated AI-EMERGE, a clinical study for the AI-Genomics blood test, which will collect samples from up to 3,000 patients in the U.S. and Canada. Freenome CEO, Gabe Otte said the infusion of AI is a natural step in the evolution of diagnostics that should have been taken years ago. “If you look at the traditional molecular diagnostic tests that are out there – the PSA tests for example &ndash...
Source: MDDI - May 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

Adding Blue Dye to Colonoscopy May Boost Detection
Spotting polyps during a colonoscopy can be tricky, particularly when they're flat or small (under 5 millimeters), one expert in the United States said. (Source: WebMD Health)
Source: WebMD Health - May 22, 2018 Category: Consumer Health News Source Type: news

Blue dye tablet helps identify polyps during colonoscopy
(Digestive Disease Week) Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer (CRC). When used in conjunction with colonoscopy, the blue dye increased adenoma detection rate (ADR) by nearly 9 percent, according to a study scheduled for presentation at Digestive Disease Week ® (DDW) 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
Their study of almost 16,000 patients who underwent colonoscopy found that the long-term risk for colon cancer was 2.5 times greater for those with advanced polyps, compared to people without such growths. (Source: WebMD Health)
Source: WebMD Health - May 16, 2018 Category: Consumer Health News Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
Title: Colon Polyp Type May Be Key to Cancer RiskCategory: Health NewsCreated: 5/15/2018 12:00:00 AMLast Editorial Review: 5/16/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 16, 2018 Category: Cancer & Oncology Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
(Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 15, 2018 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Preventive Medicine, News, Source Type: news

Colon Polyp Type May Be Key to Cancer Risk
TUESDAY, May 15, 2018 -- The type of colon polyp that's spotted during a colonoscopy may help predict the likelihood of colon cancer, new research shows. These polyps -- also called adenomas -- can be labeled advanced or non-advanced, explained... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 15, 2018 Category: General Medicine Source Type: news

CRC Polyps May Allow for Immune Checkpoint Inhibitors in Premalignant Lesions
Colorectal carcinomas in LS patients appear in background of mismatch repair (MMR) deficiency, show a unique immune profile, and response to immunotherapy. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Check-Cap closes $20m Series C
Check-Cap (NSDQ:CHEK) said yesterday it closed an offering of Series C shares and warrants, raising approximately $20.2 million in total. In the offering, the Isfiya, Israel-based company floated approximately 3.2 million units for $5.50 per unit, with each unit in the offering consisting of a single ordinary share or ordinary share equivalent and a Series C warrant to purchase one ordinary share. The offering also included an underwriter’s option for an additional 478,407 shares and Series C warrants to purchase up to 478,407 shares, which was exercised in full, Check-Cap said. Proceeds from the round are slate...
Source: Mass Device - May 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Wall Street Beat Check-Cap Source Type: news

Olympus inks co-development deal with Ai4gi for AI-supported colonoscopy solution
Olympus (TYO:7733) said today it inked a co-development deal with artificial intelligence joint venture Ai4gi which will give Olympus exclusive rights to offer Ai4gi’s AI solution designed for clinical decision support during colonoscopy screening and surveillance procedures. Ai4gi is a joint venture between Imagia and Satis Operations, Tokyo-based Olympus said. The company added that the co-development agreement is intended to improve clinical outcomes during colonoscopy procedures, reduce costs and improve quality of life for patients. “Ai4gi’s solutions to early colon cancer recognition are going ...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Software / IT ai4gi Olympus Source Type: news

Precancerous colon polyps in patients with Lynch syndrome exhibit immune activation
(University of Texas M. D. Anderson Cancer Center) Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk, display immune system activation well before cancer development, according to research from The University of Texas MD Anderson Cancer Center. The preclinical research challenges traditional models of cancer immune activation and suggests immunotherapy may be useful for colorectal cancer prevention in certain high-risk groups. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 16, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Is it normal to have brown spotting after menopause?
Many women wonder whether dark brown spotting is a normal occurrence after menopause. In this article, we look at the possible causes of postmenopausal bleeding, including vaginal atrophy, HRT, infections, and polyps. We also look at whether spotting is a sign of cancer and when someone should see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2018 Category: Consumer Health News Tags: Menopause Source Type: news

Sinus Implant Launches During Start of Strong Allergy Season
Intersect ENT is launching its Sinuva Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.  The Menlo Park, CA-based company said nearly 635,000 Americans have gone through these surgeries and are looking for treatments to cure side effects. Sinuva’s targeted launch comes at an opportune time – right in the middle of allergy season. “We were really looking at the launch regardless of the time of year,” Susan Stinson, general manager at Intersect ENT, told MD+DI. “The timing however, we believe works out very much in our ...
Source: MDDI - April 2, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Business Source Type: news

Intersect ENT launches Sinuva steroid-releasing sinus implant
Intersect ENT (NSDQ:XENT) launched its steroid-releasing sinus implant, Sinuva, in the U.S. today. The company’s drug-eluting device is designed to treat nasal polyp disease in patients who have undergone previous sinus surgery. Sinuva is placed during a routine doctor’s office visit and releases an anti-inflammatory steroid, mometasone furoate, directly to the patient’s nasal polyps for up to 90 days. Get the full story at our sister site, Drug Delivery Business News. The post Intersect ENT launches Sinuva steroid-releasing sinus implant appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - April 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Implants Otolaryngology Ear, Nose & Throat Pharmaceuticals Regulatory/Compliance Wall Street Beat intersectent Source Type: news

Science Saturday: Identifying characteristics of colon polyps most likely to progress to cancer
Researchers at Mayo Clinic are closer to answering the question, why does one colon polyp transform to cancer while another seemingly identical polyp does not? A colon polyp is a small clump of cells that forms on the lining of the colon. While most colon polyps are harmless some can develop into colon cancer, which [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - March 31, 2018 Category: Research Source Type: news

Too much low-grade calcium supplementation linked to increased risk of colon polyps
(Natural News) When scientists set out to find out whether calcium supplements could help reduce the chances of a person developing colon polyps, they were very surprised when they discovered the opposite effect. Their findings are a perfect example of why it’s important to use caution when it comes to using certain supplements. Polyps are... (Source: NaturalNews.com)
Source: NaturalNews.com - March 29, 2018 Category: Consumer Health News Source Type: news

Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas
This Cochrane Review has led to a practice changing update on DynaMed Plus. It concludes that dietary fiber with wheat bran, ispaghula husk, or high fiber sources of food might increase risk of colorectal cancer in patients with history of adenomatous polyps. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 28, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Viagra may cut colorectal cancer risk by half
A new study in mice finds that a small daily intake of Viagra can reduce the formation of potentially cancerous polyps by 50 percent. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 21, 2018 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

Could VIAGRA prevent colorectal cancer?
Scientists at Augusta University found that Viagra halved the risk of forming polyps, an abnormal clump of cells on the lining of the intestines that have the potential to turn into cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2018 Category: Consumer Health News Source Type: news

A small, daily dose of Viagra may reduce colorectal cancer risk
(Medical College of Georgia at Augusta University) A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.Viagra cut in half the formation of polyps, an abnormal and often asymptomatic clump of cells on the lining of the intestines that may become cancer, says Dr. Darren D. Browning, cancer researcher at the Georgia Cancer Center and Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2018 Category: International Medicine & Public Health Source Type: news

Calcium supplements may increase risk of abnormal bowel growths
Calcium supplements, taken with or without vitamin D, may increase the risk of polyps growing in the colon, suggest researchers following a large US trial. (Source: Nursing Times)
Source: Nursing Times - March 5, 2018 Category: Nursing Source Type: news

Calcium Supplements Tied to Higher Odds of Colon Polyps
(Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - March 3, 2018 Category: Cancer & Oncology Source Type: news

Polyp Risk Rises with Calcium Supplements (CME/CE)
(MedPage Today) -- Elevated with or without vitamin D3 (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 2, 2018 Category: Gastroenterology Source Type: news

Medical News Today: Calcium and vitamin D supplements may raise risk of polyps
Analysis of data from a large trial found calcium with and without vitamin D raised risk of colorectal polyps 6 –10 years after starting on the supplements. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 2, 2018 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

Calcium Supplements Tied to Higher Odds of Colon Polyps
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 2, 2018 Category: Cancer & Oncology Tags: Oncology, Orthopedics, Rheumatology, Nutrition, News, Source Type: news

Calcium Supplements Up Odds of Colon Polyps
Polyps are not cancerous, but some can eventually turn into cancer if they're not removed. (Source: WebMD Health)
Source: WebMD Health - March 2, 2018 Category: Consumer Health News Source Type: news

Calcium Supplements Tied to Higher Odds of Colon Polyps
FRIDAY, March 2, 2018 -- Could the calcium supplement you take to help your bones be harming your colon? That's the suggestion from a new study that finds a link between the daily supplement and an increased risk for polyps in the colon. Polyps... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 2, 2018 Category: General Medicine Source Type: news

Calcium Supplements Tied to Higher Odds of Colon Polyps
Title: Calcium Supplements Tied to Higher Odds of Colon PolypsCategory: Health NewsCreated: 3/2/2018 12:00:00 AMLast Editorial Review: 3/2/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 2, 2018 Category: Cancer & Oncology Source Type: news

Calcium Supplements Up Risk for Precancerous Serrated Polyps Calcium Supplements Up Risk for Precancerous Serrated Polyps
Rather than reducing risk, a randomized chemoprevention trial of calcium and vitamin D supplementation showed an increased risk for serrated sessile adenomas or polyps during follow-up.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Colon Polyps and Diverticulitis Symptoms and Signs
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 21, 2018 Category: General Medicine Source Type: news

Polyp Burden Drops With Sulindac/Erlotinib Combo in FAP
Patients with familial adenomatous polyposis have an increased risk for colorectal polyps and cancer; however, treatment with a combination of sulindac and erlotinib reduced their colorectal polyp burden by more than two thirds. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Genetic Disorders News Source Type: news

Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Individuals with sporadic colorectal cancer (CRC) frequently harbor abnormalities in the composition of the gut microbiome; however, the microbiota associated with precancerous lesions in hereditary CRC remains largely unknown. We studied colonic mucosa of patients with familial adenomatous polyposis (FAP), who develop benign precursor lesions (polyps) early in life. We identified patchy bacterial biofilms composed predominately of Escherichia coli and Bacteroides fragilis. Genes for colibactin (clbB) and Bacteroides fragilis toxin (bft), encoding secreted oncotoxins, were highly enriched in FAP patients’ colonic muc...
Source: ScienceNOW - February 1, 2018 Category: Science Authors: Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., Sears, C. L. Tags: Medicine, Diseases, Microbiology reports Source Type: news

Gone fishin': decorator crabs use other species as fishing rods, study reveals
A researcher ’s diving holiday lead to a startling discovery of never-before-seen behaviour: crabs using hydrozoans as fishing hooksEvery night as the sun goes down, on the coral reefs of the Red Sea small, delicate and slightly fuzzy-looking crabs work their way through the maze of coral. They take up stations atop the corals ’ outermost structures, exposing themselves to the current in the plankton-rich waters. These are decorator crabs, of the genusAchaeus, known for their peculiar habit of covering themselves with an array of invertebrates, including delicate hydrozoans: multi-headed creatures with tiny ten...
Source: Guardian Unlimited Science - January 30, 2018 Category: Science Authors: Richard Aspinall Tags: Science Marine life Environment Wildlife Biology Animal behaviour Source Type: news

Colon Polyps (Symptoms, Causes, Types, Treatment, Prevention)
Title: Colon Polyps (Symptoms, Causes, Types, Treatment, Prevention)Category: Diseases and ConditionsCreated: 12/7/1998 12:00:00 AMLast Editorial Review: 1/26/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 26, 2018 Category: Nutrition Source Type: news

Better Visualization Means No Need for Peri-polyp Biopsy in IBD Better Visualization Means No Need for Peri-polyp Biopsy in IBD
Biopsying the flat mucosa surrounding dysplastic polyps in patients with inflammatory bowel disease (IBD) may not change clinical outcomes, according to new findings.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 16, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Check-Cap wins CE Mark for C-Scan diagnostic capsule
Check-Cap (NSDQ:CHEK) said today it won CE Mark approval in the European Union for its C-Scan ingestible sensor capsule designed for colorectal cancer screening. The Israel-based company’s C-Scan system is desgiend as an alternative to standard colon cancer screaning methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless tracking system to return structural information on the lumen of the colon to create 2D and 3D maps. Physicians can use maps created by the system to identify pre-cancerous polyps and other abnormalities, Check-Cap said. “Achieving CE Mark approval is a si...
Source: Mass Device - January 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Regulatory/Compliance Check-Cap Source Type: news

Hologic wins CE Mark for MyoSure Manual
Hologic (NSDQ:HOLX) said today it won CE Mark approval in the European Union for its MyoSure Manual device. The MyoSure Manual device features an integrated vacuum with no external suction required, the Marlborough, Mass.-based company said. The system is supported by a one-liter bag of saline without the need for a controller or fluid management equipment. “There is an increased demand to simplify tissue removal procedures regardless of where they are being performed, in-office or in the theater. We continuously look to meet this need by developing innovative solutions that provide flexibility and convenie...
Source: Mass Device - January 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Women's Health Hologic Source Type: news

Tiny polyps save corals from predators and disease
(European Commission Joint Research Centre) Corals may have unexpected allies in improving their health and resilience. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 22, 2017 Category: Biology Source Type: news

By a nose: Menlo Park company moves from nasal devices to drugs with latest approval
Intersect ENT Inc. won Food and Drug Administration approval for a sinus implant that delivers an anti-inflammatory steroid to treat nasal polyps. It isn't the Menlo Park company's (NASDAQ: XENT) first product to be greenlighted by regulators — Intersect's previous three products were medical devices — but it is the first to be approved as a drug. Sinuva is placed within a sinus implant, which is put in during a routine visit to a docto r's office. It expands into the sinus cavity and delivers… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 12, 2017 Category: Health Management Authors: Ron Leuty Source Type: news

By a nose: Menlo Park company moves from nasal devices to drugs with latest approval
Intersect ENT Inc. won Food and Drug Administration approval for a sinus implant that delivers an anti-inflammatory steroid to treat nasal polyps. It isn't the Menlo Park company's (NASDAQ: XENT) first product to be greenlighted by regulators — Intersect's previous three products were medical devices — but it is the first to be approved as a drug. Sinuva is placed within a sinus implant, which is put in during a routine visit to a docto r's office. It expands into the sinus cavity and delivers… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 12, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

By a nose: Peninsula company moves from nasal devices to drugs with latest approval
Intersect ENT Inc. won Food and Drug Administration approval for a sinus implant that delivers an anti-inflammatory steroid to treat nasal polyps. It isn't the Menlo Park company's (NASDAQ: XENT) first product to be greenlighted by regulators — Intersect's previous three products were medical devices — but it is the first to be approved as a drug. Sinuva is placed within a sinus implant, which is put in during a routine visit to a docto r's office. It expands into the sinus cavity and delivers… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 12, 2017 Category: Health Management Authors: Ron Leuty Source Type: news